Kewalramani Reshma bought VRTX
February 7, 2024 · Form 4 insider transaction
Kewalramani Reshma bought 20,327 shares of Vertex Pharmaceuticals Incorporated at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
20,327
Price
$0.00
Total value
N/A
InsiderKewalramani Reshma
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 7, 2024
Filing dateFebruary 8, 2024
Shares owned after170,526
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Restricted stock unit award that vests in installments beginning on 02/17/2025.